Select Publications
Journal articles
2024, 'Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022', Clinical Rheumatology, 43, pp. 1823 - 1832, http://dx.doi.org/10.1007/s10067-024-06967-8
,2024, 'Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings', Internal Medicine Journal, 54, pp. 795 - 801, http://dx.doi.org/10.1111/imj.16296
,2024, 'Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis', Seminars in Arthritis and Rheumatism, 65, http://dx.doi.org/10.1016/j.semarthrit.2024.152383
,2024, 'The OMERACT whole-body MRI scoring system for inflammation in peripheral joints and entheses (WIPE) in spondyloarthritis - reference image atlas for the knee region', Seminars in Arthritis and Rheumatism, 65, http://dx.doi.org/10.1016/j.semarthrit.2024.152384
,2024, 'A review and recommendations on the management of psoriatic arthritis in Australia 2024', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.16557
,2023, 'Magnetic resonance imaging RAMRIS-SAFE score—A low-risk effective measure of rapid response to therapy in rheumatoid arthritis clinical trials', International Journal of Rheumatic Diseases, 26, pp. 1960 - 1966, http://dx.doi.org/10.1111/1756-185X.14847
,2023, 'RheuMetric Quantitative 0 to 10 Physician Estimates of Inflammation, Damage, and Distress in Rheumatoid Arthritis: Validation Against Reference Measures', ACR Open Rheumatology, 5, pp. 511 - 521, http://dx.doi.org/10.1002/acr2.11574
,2023, 'Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’', Annals of the Rheumatic Diseases, 82, http://dx.doi.org/10.1136/annrheumdis-2022-222161
,2023, 'Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set', ACR Open Rheumatology, 5, pp. 345 - 353, http://dx.doi.org/10.1002/acr2.11577
,2023, 'Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia', JAMA Network Open, 6, pp. E2320851, http://dx.doi.org/10.1001/jamanetworkopen.2023.20851
,2023, 'Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults', New England Journal of Medicine, 388, pp. 595 - 608, http://dx.doi.org/10.1056/nejmoa2209604
,2023, 'Comparative validation of the knee inflammation MRI scoring system and the MRI osteoarthritis knee score for semi-quantitative assessment of bone marrow lesions and synovitis-effusion in osteoarthritis: an international multi-reader exercise', Therapeutic Advances in Musculoskeletal Disease, 15, http://dx.doi.org/10.1177/1759720X231171766
,2023, 'AB0249 RHEUMETRIC QUANTITATIVE 0-10 PHYSICIAN ESTIMATES OF INFLAMMATION, DAMAGE, AND DISTRESS IN RHEUMATOID ARTHRITIS: VALIDATION AGAINST REFERENCE MEASURES', Scientific Abstracts, pp. 1308.3 - 1309, http://dx.doi.org/10.1136/annrheumdis-2023-eular.4992
,2023, 'AB1112 DESCRIPTION OF THE REAL-WORLD TREATMENT PATTERNS OF GUSELKUMAB IN THE MANAGEMENT OF PSORIATIC ARTHRITIS IN AUSTRALIA: AN ANALYSIS FROM THE OPAL DATASET', Scientific Abstracts, pp. 1785.1 - 1785, http://dx.doi.org/10.1136/annrheumdis-2023-eular.3359
,2023, 'AB1179 VARIATION OF INTER-RATER RELIABILITY FOR BONE MARROW LESION SCORES IN DIFFERENT REGIONS OF THE KNEE: A STUDY USING KIMRISS', Scientific Abstracts, pp. 1819 - 1820, http://dx.doi.org/10.1136/annrheumdis-2023-eular.1238
,2022, 'Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial', Trials, 23, pp. 743, http://dx.doi.org/10.1186/s13063-022-06589-y
,2022, 'Implementation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System in a randomized phase IIb study of abatacept in psoriatic arthritis', Rheumatology (United Kingdom), 61, pp. 4305 - 4313, http://dx.doi.org/10.1093/rheumatology/keac073
,2022, 'Computer-Assisted Image Analysis in Assessment of Peripheral Joint MRI in Inflammatory Arthritis: A Systematic Review and Meta-analysis', ACR Open Rheumatology, 4, pp. 721 - 734, http://dx.doi.org/10.1002/acr2.11450
,2022, 'Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients', Rheumatology (United Kingdom), 61, pp. 1035 - 1043, http://dx.doi.org/10.1093/rheumatology/keab449
,2022, 'Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis', Rheumatology and Therapy, 9, http://dx.doi.org/10.1007/s40744-021-00416-7
,2022, 'Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia', Clinical Rheumatology, 41, pp. 53 - 62, http://dx.doi.org/10.1007/s10067-021-05853-x
,2022, 'POS0072 CONSISTENT LONG-TERM GUSELKUMAB EFFICACY ACROSS PSORIATIC ARTHRITIS DOMAINS IRRESPECTIVE OF BASELINE PATIENT CHARACTERISTICS', Annals of the Rheumatic Diseases, 81, pp. 253 - 254, http://dx.doi.org/10.1136/annrheumdis-2022-eular.47
,2021, 'Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imaging', Seminars in Arthritis and Rheumatism, 51, pp. 1125 - 1133, http://dx.doi.org/10.1016/j.semarthrit.2021.08.004
,2021, 'Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: Post hoc analysis of FINCH 3', RMD Open, 7, pp. e001621, http://dx.doi.org/10.1136/rmdopen-2021-001621
,2021, 'Arthritis and enthesitis in the hip and pelvis region in spondyloarthritis - OMERACT validation of two whole-body MRI methods', Seminars in Arthritis and Rheumatism, 51, pp. 940 - 945, http://dx.doi.org/10.1016/j.semarthrit.2021.05.006
,2021, 'Joint and entheseal inflammation in the knee region in spondyloarthritis - reliability and responsiveness of two OMERACT whole-body MRI scores', Seminars in Arthritis and Rheumatism, 51, pp. 933 - 939, http://dx.doi.org/10.1016/j.semarthrit.2021.05.013
,2021, 'OP0149 RELIABILITY AND RESPONSIVENESS OF TWO OMERACT WHOLE-BODY MRI SCORES OF ENTHESEAL AND JOINT INFLAMMATION IN THE KNEE REGION IN SPONDYLOARTHRITIS', Annals of the Rheumatic Diseases, 80, pp. 89 - 90, http://dx.doi.org/10.1136/annrheumdis-2021-eular.755
,2021, 'OP0252 ARTHRITIS AND ENTHESITIS IN THE HIP AND PELVIS REGION IN SPONDYLOARTHRITIS – VALIDATION OF TWO WHOLE-BODY MRI METHODS', Annals of the Rheumatic Diseases, 80, pp. 153.2 - 154, http://dx.doi.org/10.1136/annrheumdis-2021-eular.952
,2021, 'POS0619 MODELLING OF DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY ARTHROPATHIES TREATED WITH ETANERCEPT ORIGINATOR OR BIOSIMILAR AS FIRST-LINE BIOLOGIC IN AN AUSTRALIAN REAL-WORLD DATASET', Annals of the Rheumatic Diseases, 80, pp. 547.1 - 547, http://dx.doi.org/10.1136/annrheumdis-2021-eular.2265
,2020, 'Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia', Clinical Rheumatology, 39, pp. 2545 - 2551, http://dx.doi.org/10.1007/s10067-020-05021-7
,2020, 'Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset', Journal of Rheumatology, 47, pp. 1174 - 1181, http://dx.doi.org/10.3899/jrheum.190535
,2020, 'Early vertebroplasty within 3 weeks of fracture for acute painful vertebral osteoporotic fractures: subgroup analysis of the VAPOUR trial and review of the literature', European Spine Journal, 29, pp. 1606 - 1613, http://dx.doi.org/10.1007/s00586-020-06362-2
,2020, 'Cochrane vertebroplasty review misrepresented evidence for vertebroplasty with early intervention in severely affected patients', BMJ Evidence-Based Medicine, 25, pp. 85 - 89, http://dx.doi.org/10.1136/bmjebm-2019-111171
,2020, 'Emerging Imaging Techniques in Spondyloarthritis: Dual-Energy Computed Tomography and New MRI Sequences', Rheumatic Disease Clinics of North America, 46, pp. 287 - 296, http://dx.doi.org/10.1016/j.rdc.2020.01.010
,2020, 'Vertebroplasty has an important role in managing patients with severe pain when performed early and with appropriate technique', Internal Medicine Journal, 50, pp. 647 - 648, http://dx.doi.org/10.1111/imj.14830
,2020, 'Atlas of the OMERACT Heel Enthesitis MRI Scoring System (HEMRIS)', RMD Open, 6, http://dx.doi.org/10.1136/rmdopen-2019-001150
,2020, 'SAT0425 NOVEL COMPUTER-ASSISTED METHODOLOGY FOR QUANTITATIVE ASSESSMENT OF MRI TREATMENT RESPONSES TO APREMILAST IN PATIENTS WITH PSORIATIC ARTHRITIS', Annals of the Rheumatic Diseases, 79, pp. 1166.1 - 1167, http://dx.doi.org/10.1136/annrheumdis-2020-eular.1335
,2019, 'Development and validation of an OMERACT MRI whole-body score for inflammation in peripheral joints and entheses in inflammatory arthritis (MRI-WIPE)', Journal of Rheumatology, 46, pp. 1215 - 1221, http://dx.doi.org/10.3899/jrheum.181084
,2019, 'The OMERACT MRI in enthesitis initiative: Definitions of key pathologies, suggested MRI sequences, and a novel heel enthesitis scoring system', Journal of Rheumatology, 46, pp. 1232 - 1238, http://dx.doi.org/10.3899/jrheum.181093
,2019, 'Utility of magnetic resonance imaging in diagnosis and monitoring enthesitis in patients with spondyloarthritis: An OMERACT systematic literature review', Journal of Rheumatology, 46, pp. 1207 - 1214, http://dx.doi.org/10.3899/jrheum.181083
,2019, 'Validity and responsiveness of combined inflammation and combined joint damage scores based on the OMERACT rheumatoid arthritis MRI scoring system (RAMRIS)', Journal of Rheumatology, 46, pp. 1222 - 1227, http://dx.doi.org/10.3899/jrheum.181064
,2019, 'Percutaneous Vertebroplasty for Acute Painful Osteoporotic Vertebral Fractures—Benefits Shown in VAPOUR Trial Masked When Pooled With Other Clinical Trials', Journal of Bone and Mineral Research, 34, pp. 1182 - 1184, http://dx.doi.org/10.1002/jbmr.3725
,2019, 'Imaging in the Mobile Domain', Rheumatic Disease Clinics of North America, 45, pp. 291 - 302, http://dx.doi.org/10.1016/j.rdc.2019.01.002
,2019, 'Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib', RMD Open, 5, http://dx.doi.org/10.1136/rmdopen-2018-000742
,2018, 'Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population', Rheumatology and Therapy, 5, pp. 383 - 401, http://dx.doi.org/10.1007/s40744-018-0118-2
,2018, 'Effectiveness of biologics in Australian patients with rheumatoid arthritis: a large observational study: REAL', Internal Medicine Journal, 48, pp. 1185 - 1192, http://dx.doi.org/10.1111/imj.14028
,2018, 'A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population', International Journal of Rheumatic Diseases, 21, pp. 1581 - 1590, http://dx.doi.org/10.1111/1756-185X.13243
,2018, 'A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis – the HUMOR trial', Osteoarthritis and Cartilage, 26, pp. 880 - 887, http://dx.doi.org/10.1016/j.joca.2018.02.899
,2018, 'Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: Results of the randomized, placebocontrolled PALACE 4 trial', Rheumatology (United Kingdom), 57, pp. 1253 - 1263, http://dx.doi.org/10.1093/rheumatology/key032
,2018, 'Evaluation of the effect of baseline MRI sacroiliitis and c reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: A post hoc analysis of the EMBARK study', Annals of the Rheumatic Diseases, 77, pp. 1090 - 1093, http://dx.doi.org/10.1136/annrheumdis-2017-211313
,